Clinical Trials Browser

Glioma × cemiplimab × 1 year × Clear all

NCT07567469 2026-05-05

A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma

Phase 1/2 Not yet recruiting

Ependymoma, Glioma, Neoplasms, Recurrence

NCT04826393 2025-10-22

ASP8374 + Cemiplimab in Recurrent Glioma

Phase 1 Completed

Glioblastoma, Glioma, Lymphoma, Follicular